Therapeutic B-cell depletion reverses progression of Alzheimer’s disease
Alzheimer’s disease is characterized by progressive dementia and amyloid beta plaque deposition. Here the authors show in three relevant transgenic animal models that accumulation of activated B cells is central to AD pathology and depletion of B cells interferes with both histological and behaviour...
Guardado en:
Autores principales: | Ki Kim, Xin Wang, Emeline Ragonnaud, Monica Bodogai, Tomer Illouz, Marisa DeLuca, Ross A. McDevitt, Fedor Gusev, Eitan Okun, Evgeny Rogaev, Arya Biragyn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/44ad602eff5f455e94eb988bbdc2dcdc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis
por: Tomer Illouz, et al.
Publicado: (2021) -
Metabolic effects of acute thiamine depletion are reversed by rapamycin in breast and leukemia cells.
por: Shuqian Liu, et al.
Publicado: (2014) -
Aggregate-depleted brain fails to induce Aβ deposition in a mouse model of Alzheimer's disease.
por: Claudia Duran-Aniotz, et al.
Publicado: (2014) -
Age-Related Changes in Plasma Extracellular Vesicle Characteristics and Internalization by Leukocytes
por: Erez Eitan, et al.
Publicado: (2017) -
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model
por: Elizabeth Spangenberg, et al.
Publicado: (2019)